Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: LIFE TECHNOLOGIES CORPORATION
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2023-09-25 to 2023-11-09
Current total value of award: $17500
Description: PURCHASE ANTI-ANTHRAX TOXIN ANTIBODY, OBILTOXAXIMAB, IN A SINGLE GLASS VIAL AT THE CONCENTRATION OF 10 MG/ML.